Diabetic macular edema;Edema macular diabético

Anales del Sistema Sanitario de Navarra

Volumn 31, Issue SUPPL. 3, 2008, Pages 35-44

  Andonegui, J ^a   Lasanta, L Jiménez ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Diabetes mellitus; Diabetic macular edema

Indexed keywords

DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DISEASE CLASSIFICATION; HUMAN; PATHOPHYSIOLOGY; REVIEW; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

COMBINED MODALITY THERAPY; DIABETES COMPLICATIONS; HUMANS; HYPOGLYCEMIC AGENTS; LASER THERAPY; MACULAR EDEMA;

EID: 63849223096     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. MOSS SE, KLEIN R, KLEIN BE. The incidence of vision loss in a diabetic population. Ophthalmology 1988; 95: 1340-1348.
2. KIM BY, SMITH SD, KAISER PK. OPTICAL coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol 2006; 142:405-412.
3. DCCT Research Group. The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin-dependent diabetes. N Engl J Med 1993: 329: 977-986.
4. UK Prospective Diabetes Study (UKPDS) Group. intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 317: 703713.
5. The Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report n° 1. Arch Ophthalmol 1985;103:1796-1806.
6. JONAS JB, SOFKER A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132: 425427.
7. MARTIDIS A, DUKER JS, GREENBERG PB, ROGERS AH, PULIAFITO CA, REICHEL E et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920-927.
8. JONAS JB, KREISING I, SOFKER K, DEGENRING RF. intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121: 57-61.
9. Macugen Diabetic Retinopathy Study Group. A phase II randomized double-masked trial of pegaptanib, an antivascular endothelial growth factor aptamer for diabetic macular edema. Ophthalmology 2005; 112: 1747-1757.
10. CHUN DW, HEIER JS, TOPPING TM, DUKER JS, BANKERT JM. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 2006; 113: 1706-1712
11. KIMURA T, KIRYU J, NISHIWAKI H, OH H, SUZUMA K, WATANABE D et al. Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina 2005; 25: 454-461.
12. PATEL JI, HYKIN PG, SCHADT M, LUONG WY, FITZKE F, GREGOR ZJ. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 2006; 26: 5-13.
13. NGUYEN QD, SHAH SM, vAN ANDEN E et al. Supplemental inspired oxigen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci 2003; 45-617-624.
14. DEREVJANIK NL, VINORES SA, XIAO W-H, MORI K, TURON T, HUDISH T et al. Quantitative assessment of the integrity of the blood- retinal barrier in mice. invest ophthalmol Vis Sci 2002; 43: 2462-2467.
15. BRESNICK GH. Diabetic macular edema. A review. ophthalmology 1986; 93: 989-997.
16. WILKINSON CP, FERRIS FL, KLEIN RE, LEE PP, AGARDH CD, DAVIS M et al. Proposed International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales. Ophthalmology 2003;110: 1677-1682.
17. OTANI T, KISHI S, MARUYAMA Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999; 127: 688-693.
18. PIRES I, BERNARDES RC, LOBO CL, SOARES MA, CUNHA-VAZ JG. Retinal thickness in eyes with mild nonproliferative retinopathy in patients with type 2 diabetes mellitus: comparison of measurements obtained by retinal thickness analysis and optical coherence tomography. Arch Ophthalmol 2002; 120: 1301-1306.
19. BANDELLO F, LANZETTA P, MENCHINI U. When and how to do a grid laser for diabetic macular edema. Doc Ophthalmol 1999; 97: 415-419.
20. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991; 98: 766-785.
21. LEE CM, OLK RJ. Modified grid laser fotocoagulation for diffuse diabetic macular edema: long term visual results. Ophthalmology 1991; 98: 1594-1602.
22. Early Treatment Diabetic Retinopathy Study Research group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline. ETDRS report n° 19. Arch Ophthalmol 1995; 113: 1144-1155.
23. LEWIS H, ABRAMS GW, BLUMENKRANZ MS, CAMPO RV. Vitrectomy for diabetic macular edema associated with posterior hyaloidal traction. Ophthalmology 1992; 99: 753-759.
24. TACHI N, OGINO N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996; 122: 258-260.
25. YAMAMOTO T, AKABANE N, TAKEUCHI S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 2001; 132: 369-377.
26. STEFANIOTOU M, ASPIOTIS M, KALEGEROPOULOS C et al. Vitrectomy ressults for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol 2004; 14: 137-143.
27. RADETZKY S, WALTER P, FAUSER S, KOIZUMI K, KIRCHHOF B, JOUSSEN AM. Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2004; 242: 273-278.
28. FUNATSU H, YAMASHITA H, SAKATA K, NOMA H, MIMURA T, SUZUKI M et al. Vitreous levels of vascular endotelial growth factor and intercellular adhesión molecule 1 are related to diabetic macular edema. Ophthalmology 2005; 112: 806-816.
29. INOUE M, TAKEDA K, MORITA K, YAMADA M, TANIGAWARA Y OGUCHI Y. VITREOUS concentration of triamcinolone acetonide in human eyes after intravitreal or subtenon injection. Am J Ophthalmol 2004; 138: 1046-1048.
30. MASSIN P, AUDREN F, HAOUCHINE B, ERGINAY A, BERGMANN JF, BENOSMAN R et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: Preliminary ressults of a prospective controlled trial. Ophthalmology 2004; 111: 218-225.
31. Diabetic Retinopathy Clinical Research Network. A randomized clinical trial comparing intravitreal Triamcinolonide acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008; 115: 1447-1459.
32. TUNC M, ONDER HI, KAYA M. Posterior sub-Tenon's capsule Triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema. Ophthalmology 2005; 112: 1086-1091.
33. KANG SW, SA HS, CHO HY, KIM JI. Macular grid photocoagulation after intravitreal Triamci- nolone acetonide for diffuse diabetic macular edema. Arch Ophthalmol 2006; 124:653-658.
34. SHIMURA M, NAKAZAWA T, YASUDA K, SHIONO T, NISHIDA K. Pretreatment of posterior subtenon injection of Triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema. Br J Ophthalmol 2007; 91:449-454.
35. Diabetic Retinopathy Clinical Research Network. Randomized trial of peribulbar Triamcinolonide acetonide with and without focal photocoagulation for mild diabetic macular edema. A pito study. Ophthalmology 2007; 114: 1190-1196.
36. LAM DS, CHAN CK, MOHAMED S, LAI TY, LEE WY, LIU DT et al. Intravitreal Triamcinolone plus sequential grid laser versus Triamcinolone or laser alone for treating diabetic macular edema. Six-month outcomes. Ophthalmology 2007; 114: 2162-2167.
37. 37.www.drcr.net; fecha de acceso, 12 de junio de 2008.